Study on the Physiological Role of Carbohydrate Residues in Thyroxine Binding Globulin Using Introduction of its Gene by Transfection
利用转染导入甲状腺素结合球蛋白基因研究碳水化合物残基的生理作用
基本信息
- 批准号:63480268
- 负责人:
- 金额:$ 3.07万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1988
- 资助国家:日本
- 起止时间:1988 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Thyroxine-Binding Globulin (TBG) is a principal thyroxine-binding protein in serum and is synthesized in the liver. The protein belongs to alpha1-antitrypsin family because of its structural similarity. In this investigation, physiological significance of carbohydrate moiety in TBG was studied. At first, we employed hepatome cell line HepG2 which synthesizes TBG and corticosteroid-binding globulin (CBG, also a member of alpha1-antitrypsin family). When the cell was treated with tunicamycin (inhibitor of core glycosylation), TBG was never secreted into the medium. On the other hand CBG was secreted into the medium without glycosylation. However, intracellular degradation was increased in both TBG and CBG when treated with tunicamycin. It was also noted that TBG synthesized in the presence of tunicamycin cross-reacted with anti-denatured TBG which had no thyroxine binding. Thus, it is concluded that carbohydrate moiety in TBG play important roles in T4-binding, secretion and intracellula … More r degradation.To further investigate the role of carbohydrate residues in TBG, TBG-Gary found in a patient by Murata et al was studied. TBG-Gary was characterized by decreased T4-binding, annodal shift on isoelectric focusing and heat instability. The analysis of structure of TBG genome revealed that single point mutation in exon I causes amino acid substitution of 96th amino acid "isoleucine" to "asparagine". This amino acid substitution resulted in a creation of a potential glycosylation site (asparagine-cystine-serine). Complete cDNAs coding for normal TBG as well as TBG-Gary was constructed and inserted in expression vector pEUK-C1. Transfection of the respective plasmids into Cos 1 cells and subsequent analysis by pulse-chase experiment revealed that TBG-Gary was indeed has an additional carbohydrate residues, reduced T4-binding, and cross-reacted with anti-denatured TBG. Moreover, it was demons trated that TBG-Gary was much more rapidly degraded in the cells. When the mutant asparagine residue in TBG-Gary was substituted to aspartic acid by site-specific mutagenesis, the mutated TBG behaved like normal TBG.These studies demonstrate that carbohydrate residues in TBG play important role in hormone binding, cellular transport, and metabolism. Less
甲状腺素结合球蛋白(TBG)是血清中主要的甲状腺素结合蛋白,在肝脏中合成。由于其结构相似,该蛋白属于α 1-抗胰蛋白酶家族。本研究对TBG中碳水化合物的生理意义进行了研究。首先,我们使用了合成TBG和皮质类固醇结合球蛋白(CBG,也是α 1-抗胰蛋白酶家族的成员)的肝细胞系HepG 2。当细胞用衣霉素(核心糖基化抑制剂)处理时,TBG从未分泌到培养基中。另一方面,CBG在无糖基化的情况下分泌到培养基中。然而,当用衣霉素处理时,TBG和CBG的细胞内降解增加。还注意到,在衣霉素存在下合成的TBG与不具有甲状腺素结合的抗变性TBG交叉反应。因此,TBG中的碳水化合物在T4结合、分泌和细胞内分泌中起重要作用 ...更多信息 为了进一步研究碳水化合物残基在TBG中的作用,研究了Murata等人在患者中发现的TBG-Gary。TBG-Gary的特征在于T4结合减少、等电聚焦的annodal移位和热不稳定性。TBG基因组结构分析表明,TBG基因第一外显子的单点突变导致第96位氨基酸“异亮氨酸”替换为“天冬酰胺”。该氨基酸取代导致产生潜在的糖基化位点(天冬酰胺-胱氨酸-丝氨酸)。构建了编码正常TBG和TBG-Gary的完整cDNA,并将其插入表达载体pEUK-C1中。将各质粒转染到Cos 1细胞中,随后通过脉冲追踪实验进行分析,结果显示TBG-Gary确实具有额外的碳水化合物残基,降低了T4结合,并与抗变性TBG交叉反应。此外,它是恶魔证明TBG-Gary在细胞中降解得更快。通过定点突变将TBG-Gary中的天冬酰胺残基突变为天冬氨酸后,突变的TBG表现出与正常TBG相似的行为。这些研究表明,TBG中的碳水化合物残基在激素结合、细胞转运和代谢中起着重要作用。少
项目成果
期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Seo H: "Plasma thyroxine-binding proteins and thyroid hormone levels in primate species;Is Callithricidae thyroid hormone resistant?" Endocrino1.Japon.36. 655-673 (1989)
Seo H:“灵长类动物血浆甲状腺素结合蛋白和甲状腺激素水平;Callithricidae 甲状腺激素是否具有抗性?”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Murata Y: "Studies on the role of glycosylation for human corticosteroid-binding globulin:Comparison with that for thyroxine-binding globulin." Endocrinology. 15. 1424-1429 (1989)
Murata Y:“人皮质类固醇结合球蛋白糖基化作用的研究:与甲状腺素结合球蛋白的比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
神部福司: "COS-1細胞への遺伝子導入によるサイロキシン結合グロブリン構造遺伝子の発現" 環境医学研究所年報. 40. 157-160 (1989)
Fukuji Kambe:“通过基因转移到 COS-1 细胞中表达甲状腺素结合球蛋白结构基因”环境医学研究所年度报告 40. 157-160 (1989)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukushi Kambe: "Cloning of a complementary deoxyribonucleic acid coding for human thyroxineーbinding globulin(TBG):Existence of two TBG mesenger ribonucleic acid species" Molecular Endocrinology. 2. 181-185 (1988)
Fukushi Kambe:“编码人甲状腺素结合球蛋白 (TBG) 的互补脱氧核糖核酸的克隆:两种 TBG 信使核糖核酸种类的存在”《分子内分泌学》2. 181-185 (1988)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y. Murata, K. Sueda, H. Seo, N. Matsui: "Studies on the role of glycosylation for human cortico-steroid-binding globulin : Comparison with that for thyroxine-binding globulin" Endocrinology. Volume 125. 1424-1429 (1989)
Y. Murata、K. Sueda、H. Seo、N. Matsui:“人皮质类固醇结合球蛋白糖基化作用的研究:与甲状腺素结合球蛋白的比较”内分泌学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEO Hisao其他文献
Thyroid hormone enhances neuronal survival through activating PI3K-Akt signaling cascade.
甲状腺激素通过激活 PI3K-Akt 信号级联来增强神经元存活。
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
CAO Xia;KAMBE Fukushi;SEO Hisao - 通讯作者:
SEO Hisao
DHCR24-knockout embryonic fibroblasts are susceptible to the apoptosis induced by serum withdrawal because of dysfunction of caveolae and insulin-Akt-Bad signaling.
由于小凹和胰岛素-Akt-Bad 信号传导功能障碍,DHCR24 敲除的胚胎成纤维细胞容易受到血清撤药诱导的细胞凋亡的影响。
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
LU Xiuli;KAMBE Fukushi;CAO Xia;SEO Hisao - 通讯作者:
SEO Hisao
SEO Hisao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEO Hisao', 18)}}的其他基金
Functional analysis of a novel signaling cascade activated by thyroid hormone: Role of PI3 kinase→PKB→mTOR→ZAKI-4αactivation by thyroid hormone
甲状腺激素激活的新型信号级联的功能分析:甲状腺激素激活PI3激酶→PKB→mTOR→ZAKI-4α的作用
- 批准号:
16390269 - 财政年份:2004
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Crosstalk between Ca^<2+>-calcineurin-pathway and thyroid hormone action
Ca^<2>-钙调磷酸酶途径与甲状腺激素作用之间的串扰
- 批准号:
13470217 - 财政年份:2001
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
FUNCTION OF COFACTORS MODIFYING THYROID HORMONE RECEPTOR FUNCTION
辅助因子改变甲状腺激素受体功能的功能
- 批准号:
10470226 - 财政年份:1998
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
REGULATION OF THYROID FUNCTION BY TRANSCRIPTION FACTOR NF-kappaB
转录因子 NF-κB 对甲状腺功能的调节
- 批准号:
07457222 - 财政年份:1995
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
INTERFERON-b GENE THERAPY FOR VIRAL HEPATITIS
病毒性肝炎的干扰素-b 基因治疗
- 批准号:
05557033 - 财政年份:1993
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Cloning of homeobox genes involved in the differentiation of placental cells producing peptide hormones
涉及产生肽激素的胎盘细胞分化的同源盒基因的克隆
- 批准号:
04454559 - 财政年份:1992
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Thyroxine-binding globulin, Molecular biology of the gene and its abnormal expressions
甲状腺素结合球蛋白,基因的分子生物学及其异常表达
- 批准号:
60480267 - 财政年份:1985
- 资助金额:
$ 3.07万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Development of Site-Specific Mutagenesis in Coxiella burnetti
伯内蒂柯克斯体定点诱变的发展
- 批准号:
8206476 - 财政年份:2010
- 资助金额:
$ 3.07万 - 项目类别:
EAPSI: Improving the Monomer-Supplying Function of FabH for Polyhdroxyalkanoate Production Through Site-Specific Mutagenesis
EAPSI:通过定点诱变改善聚羟基链烷酸酯生产中 FabH 的单体供应功能
- 批准号:
1015089 - 财政年份:2010
- 资助金额:
$ 3.07万 - 项目类别:
Fellowship Award
Development of Site-Specific Mutagenesis in Coxiella burnetti
伯内蒂柯克斯体定点诱变的发展
- 批准号:
8029852 - 财政年份:2010
- 资助金额:
$ 3.07万 - 项目类别:
SITE SPECIFIC MUTAGENESIS OF H PYLORI CARBONIC ANHYDRASE
幽门螺杆菌碳酸酐酶的位点特异性诱变
- 批准号:
2879847 - 财政年份:1999
- 资助金额:
$ 3.07万 - 项目类别: